Anna Gruzman, Pharm.D., currently serves as the Director of Regulatory Affairs at BridgeBio since April 2024. Prior to this role, Anna held various positions at Exelixis, including Director of Regulatory Affairs and Associate Director of Regulatory Affairs from February 2022 to April 2024. Anna's experience at Genentech spanned from July 2016 to January 2022, where roles included Associate Program Director and Program Manager in Regulatory Affairs, as well as a Post-Doctoral Fellow in the same field. Anna also contributed as Adjunct Faculty at Rutgers University from July 2016 to April 2018 and completed several clerkships at renowned institutions, such as Eli Lilly, Stanford Health Care, and Kaiser Permanente. Anna holds a Doctor of Pharmacy degree from the University of California, San Francisco (2012-2016) and a Bachelor's degree in Human Biology from UC San Diego (2007-2011).
This person is not in any teams
This person is not in any offices